Cardica surges to Q1 profits
Cardica Inc. (NSDQ:CRDC) posted profits of $6.2 million, or 25 cents per share, on sales of $10.0 million during the three months ended Sept. 30. That compares with losses of $2.7 million, or 17 cents per diluted share, on sales of $947,000 during the same period last year.
Read more

Interleukin Genetics halves Q3 losses on 69 percent sales surge
Interleukin Genetics Inc. (NSDQ:ILIU) posted losses of $1.4 million, or 4 cents per diluted share, on sales of $545,000 during the three months ended Sept. 30. That compares with losses of $2.5 million, or 8 cents per diluted share, on sales of $323,000 during the same period last year.
Read more

Corgenix swings to Q1 losses
Corgenix Medical Corp. (OTC:CONX) posted losses of $348,000, or 1 cent per diluted share, on sales of $2.0 million during the three months ended Sept. 30. That compares with profits of $7,000, or no cents per share, on sales of $2.0 million during the same period last year.
Read more

Guided Therapeutics slashed losses by percent
Guided Therapeutics Inc. (OTC:GTHP) posted losses of $635,000, or 1 cent per diluted share, on sales of $676,000 during the three months ended Sept. 30. That compares with losses of $2.1 million, or 12 cents per diluted share, on sales of $577,000 during the same period last year.
Read more

American Bio Medica pares losses on sales uptick
American Bio Medica Corp. (OTC:ABMC) posted losses of $300,000, or 1 cent per diluted share, on sales of $2.5 million during the three months ended Sept. 30. That compares with losses of $241,000, or 1 cent per diluted share, on sales of $2.5 million during the same period last year.
Read more

Dynatronics profits sink to a whisper
Dynatronics Corp. (NSDQ:DYNT) reported profits of $17,012, less than 1 cent per diluted share, on revenue of $7.9 million during the three months ended Sept. 30. That compares with profits of $68,625 million, or 1 cent per diluted share, on revenue of $8.2 million during the same period last year.
Read more

Vermillion reports revenue for Q3
Vermillion Inc. (NSDQ:VRML) reported a loss of $2.7 million, or 26 cents per diluted share, on revenue of approximately $413,000 during the three months ended Sept. 30. That compares with a loss of $11.0 million, or $1.72 per diluted share, with no revenue during the same period last year.
Read more

Datatrack posts first positive year to year EPS in five years
Datatrack International Inc. (NSDQ:DATA) posted profits of $48,636, less than one cent per diluted share, on sales of $1.8 million during the three months ended Sept. 30. That compares with a loss of $423,856, or 3 cents per diluted share, on sales of $1.6 million during the same period last year.
Read more

CAS Medical Systems drops into the red on lower sales
CAS Medical Systems Inc. (NSDQ:CASM) reported a net loss of $508,247, or 4 cents per diluted share, on sales of $7.8 million during the three months ended Sept. 30. That compares with a profit of $197,138 million, or 2 cents per diluted share, on sales of $9.2 million during the same period last year.
Read more

VirtualScopics edges into the black
VirtualScopics Inc. (NSDQ:VSCP) reported profits of $588,179, or 2 cents per diluted share, on sales of $3.6 million during the three months ended Sept. 30. That compares with a loss of $291,383, or 1 cent per diluted share, on sales of $2.8 million during the same period last year.
Read more